C
Coherence Bio develops the Touchstone DX, a compact, automated system for fast and accurate molecular diagnostics. This platform supports on-demand, random-access testing with minimal hands-on time for various infectious disease targets. The solution brings lab-quality viral and bacterial detection closer to the patient for improved decentralized care.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Coherence Bio develops decentralized molecular diagnostics solutions for fast and accurate pathogen detection. Their Touchstone DX system offers an automated, small-footprint platform for on-demand testing with minimal hands-on time. This enables lab-quality results closer to the patient for improved clinical decision-making in various settings.